Critical Analysis of Stage IV Epithelial Ovarian Cancer Patients after Treatment with Neoadjuvant Chemotherapy followed by Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CRS/HIPEC).
Carlos A Munoz-ZuluagaArmando SardiMichelle SittigVadim GushchinMary C KingCarol NierodaMary Caitlin KingTeresa P Diaz-MontesPublished in: International journal of surgical oncology (2020)
Outcomes in select initially diagnosed and unresectable SIV EOC are similar to SIII after NACT plus CRS/HIPEC. SIV EOC may benefit from CRS/HIPEC, and further studies should explore this treatment approach.
Keyphrases
- neoadjuvant chemotherapy
- locally advanced
- end stage renal disease
- rectal cancer
- minimally invasive
- newly diagnosed
- lymph node
- chronic kidney disease
- radiation therapy
- sentinel lymph node
- peritoneal dialysis
- coronary artery bypass
- type diabetes
- patient reported outcomes
- coronary artery disease
- combination therapy
- smoking cessation